Advertisement
Advertisement
BWAY
Brainsway Ltd. - ADR
21.87
USDSponsored
+0.94
+4.51%
Feb 06, 15:59 UTC -5
Closed
After-Market
21.72
-0.15
-0.70%
BWAY Earnings Reports
Positive Surprise Ratio
BWAY beat 11 of 16 last estimates.
69%
Next Report
Date of Next Report
Mar 09, 2026
Estimate for Q4 25 (Revenue/ EPS)
$46.13M
/$0.13
Implied change from Q3 25 (Revenue/ EPS)
+1.74%
/--
Implied change from Q4 24 (Revenue/ EPS)
+9.29%
/-7.14%
Brainsway Ltd. - ADR earnings per share and revenue
On Nov 11, 2025, BWAY reported earnings of 0.13 USD per share (EPS) for Q3 25, beating the estimate of 0.09 USD, resulting in a 35.63% surprise. Revenue reached 45.34 million, compared to an expected 45.83 million, with a -1.07% difference. The market reacted with a -5.83% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of 0.13 USD, with revenue projected to reach 46.13 million USD, implying an increase of 0.00% EPS, and increase of 1.74% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Phibro Animal Health Corporation Class A
Report Date
Feb 04, 2026 For Q2 26
Estimate
$0.68
Actual
$0.87
Surprise
+27.30%
Aurora Cannabis Inc. Common Shares
Report Date
Feb 04, 2026 For Q3 26
Estimate
$0.21
Actual
$0.12
Surprise
-42.72%
High Tide Inc. Common Shares
Report Date
Jan 29, 2026 For Q4 25
Estimate
$0.00
Actual
-$0.56
Surprise
0.00%
Stryker Corporation
Report Date
Jan 29, 2026 For Q4 25
Estimate
$4.43
Actual
$4.47
Surprise
+0.69%
Boston Scientific Corp.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$0.78
Actual
$0.80
Surprise
+1.61%
ResMed Inc.
Report Date
Jan 29, 2026 For Q2 26
Estimate
$2.75
Actual
$2.81
Surprise
+2.15%
GE HealthCare Technologies Inc. Common Stock
Report Date
Feb 04, 2026 For Q4 25
Estimate
$1.42
Actual
$1.44
Surprise
+0.96%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Feb 05, 2026 For Q4 25
Estimate
$0.32
Actual
$0.38
Surprise
+15.43%
Prestige Consumer Healthcare Inc.
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.15
Actual
$1.13
Surprise
-1.36%
Haemonetics Corporation
Report Date
Feb 05, 2026 For Q3 26
Estimate
$1.26
Actual
$1.31
Surprise
+3.75%
FAQ
What were Brainsway Ltd. - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Brainsway Ltd. - ADR reported EPS of $0.13, beating estimates by 35.63%, and revenue of $45.34M, -1.07% below expectations.
How did the market react to Brainsway Ltd. - ADR's Q3 2025 earnings?
The stock price moved down -5.83%, changed from $16.12 before the earnings release to $15.18 the day after.
When is Brainsway Ltd. - ADR expected to report next?
The next earning report is scheduled for Mar 09, 2026.
What are the forecasts for Brainsway Ltd. - ADR's next earnings report?
Based on 3
analysts, Brainsway Ltd. - ADR is expected to report EPS of $0.13 and revenue of $46.13M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement